Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16071108 | Gilteritinib | 1254053-43-4 | 98% by HPLC |  |
| Gilteritinib, also known as (ASP2215, is a potent FLT3/AXL inhibitor, which showed po | ||||
| 16071101 | GDC-0152 | 873652-48-3 | 98% by HPLC |  |
| GDC-0152 is a second mitochondrial activator of caspases (Smac) mimetic inhibitor of | ||||
| 16071032 | GSK-461364 | 929095-18-1 | 98% by HPLC |  |
| GSK-461364 is a Polo-like kinase 1 inhibitor, is also a small molecule Polo-like kina | ||||
| 16071027 | GPI-1046 | 186452-09-5 | 98% by HPLC |  |
| GPI-1046 | ||||
| 16071019 | GBR 12783 | 67469-57-2 | 98% by HPLC |  |
| GBR 12783 | ||||
| 16071018 | GW4064 | 278779-30-9 | 98% by HPLC |  |
| GW-4064 is a selective agonist of FXR (EC50 = 15 nM).2 It displays no activity at oth | ||||
| 16070905 | GSK621 | 1346607-05-3 | 98% by HPLC |  |
| GSK621 is a specific and potentAMPKactivator. | ||||
| 16070808 | GSK1210151A | 1300031-49-5 | 98% by HPLC |  |
| GSK1210151A, also known as I-BET151, is a BET bromodomain inhibitor, which blocks rec | ||||
| 16062801 | GDC-0994 | 1453848-26-4 | 98% by HPLC |  |
| GDC-0994, also known as RG7842, is an orally available inhibitor of extracellular sig | ||||
| 16060604 | GNF-7 | 839706-07-9 | 98% by HPLC |  |
| BenzaMide | ||||
| 032404 | GR148672X | 263890-70-6 | 98% |  |
| Coming soon! | ||||
| 030905 | GW501516 | 317318-70-0 | 98% |  |
| Coming soon! | ||||
| 012001 | Glesatinib(MGCD-265) | 936694-12-1 | 98% | -cas-936694-12-1.png) |
| Glesatinib is a potent tyrosine kinase inhibitor with potential antineoplastic activi | ||||
| 011909 | Gamma-Secretase Modulators | 937812-80-1 | 98% |  |
| Coming soon! | ||||
| 011809 | GLYX 13 | 117928-94-6 | 98% |  |
| Coming soon! | ||||
| 010811 | GDC-0623 | 1168091-68-6 | 98% |  |
| GDC-0623 is a potent, ATP-uncompetitive inhibitors of MEK1(Ki=0.13 nM, +ATP); 6-fold | ||||
| 010610 | Gepotidacin | 1075236-89-3 | 97% |  |
| Gepotidacin is a potent Type II DNA topoisomerase inhibitor. Gepotidacin is a novel a | ||||
| 010609 | GGTI-298 | 1217457-86-7 | 97% |  |
| GGTI-298 is a potent geranylgeranyltransferase-I (GGTase-I) inhibitor with potential | ||||
| 123008 | Givinostat | 497833-27-9 | 98% |  |
| Givinostat is an orally bioavailable hydroxymate inhibitor of histone deacetylase (HD | ||||
| 122924 | GSK2838232 | 1443461-21-9 | 98% |  |
| GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed f | ||||
| 122524 | GW2580 | 870483-87-7 | 98% |  |
| GW2580 is an orally bioavailable inhibitor of c-FMS kinase; completely inhibited huma | ||||
| 122505 | GSK-LSD1 2HCl | 1431368-48-7 | 98% |  |
| Coming soon! | ||||
| 122402 | GSK343 | 1346704-33-3 | 98% |  |
| GSK343 is a potent and selective EZH2 inhibitor with IC50 of 4 nM, showing 60 fold se | ||||
| 121430 | GSK1292263 | 1032823-75-8 | 98% |  |
| GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabet | ||||
| 121428 | GSK1904529A | 1089283-49-7 |  | |
| GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, & | ||||
| 120115 | GDC-0941 | 957054-30-7 | 98% |  |
| GDC-0941 is a potent inhibitor of PI3K/ with IC50 of 3 nM, with modest selectivity ag | ||||
| 120114 | GANT 61 | 500579-04-4 | 98% |  |
| GANT 61 is a small molecule inhibitor of Gli1 and Gli2. | ||||
| 111306 | GZD824 | 1257628-77-5 | 98% |  |
| GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T | ||||
| 111011 | GSK-1070916 | 942918-07-2 | 98% |  |
| GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3 | ||||
| 102903 | GSK2256098 | 98% |  | |
| GSK2256098 is a small molecule focal adhesion kinase (FAK) inhibitor with potential a | ||||